Gaithersburg, MD, United States of America

Nicole Kallewaard-LeLay

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal16 out of 541 
 
Medimmune Limited
 patents
silverMedal7 out of 37 
 
Humabs Biomed Sa
 patents
bronzeMedal2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Nicole Kallewaard-LeLay

Introduction

Nicole Kallewaard-LeLay, a prominent inventor based in Gaithersburg, MD, has made significant contributions to the field of biotechnology. With an impressive portfolio of 17 patents, her work primarily focuses on developing innovative solutions for combating viral infections, specifically targeting the influenza B virus and respiratory syncytial virus (RSV).

Latest Patents

Among her latest patents, one notable invention is centered around "Neutralizing anti-influenza B antibodies and uses thereof." This invention entails the development of antibodies and antigen-binding fragments capable of binding to the influenza B virus hemagglutinin (HA) and neutralizing the virus across two distinct phylogenetic lineages. The antibody is designed to effectively target both Yamagata and Victoria lineages of the influenza B virus. Another significant patent is titled "RSV-specific antibodies and functional parts thereof," which provides antibodies that specifically bind to RSV, along with methodologies for their production.

Career Highlights

Through her career, Nicole has been associated with leading biotechnology companies such as MedImmune Limited and Humabs Biomed SA. Her innovative work has not only advanced scientific understanding but has also contributed to the development of therapeutic interventions for viral diseases.

Collaborations

Throughout her career, Nicole has collaborated with esteemed colleagues including Qing Zhu and Andy Q Yuan. These collaborative efforts have allowed for the cross-pollination of ideas and the synthesis of groundbreaking technologies in the realm of antibody development.

Conclusion

Nicole Kallewaard-LeLay stands out as a leading innovator in the field of biotechnology. Her patents are a testament to her dedication to advancing medical science and providing solutions for critical health challenges. As she continues her work, Nicole remains a pivotal figure in the ongoing fight against viral infections, inspiring future generations of inventors and scientists.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…